Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
4.118
-0.312 (-7.05%)
At close: Nov 4, 2026, 4:00 PM EST
3.895
-0.223 (-5.41%)
After-hours: Nov 4, 2026, 7:30 PM EST
Revelation Biosciences Market Cap
Revelation Biosciences has a market cap or net worth of $2.34 million as of November 4, 2026. It is the 47,505th most valuable company in the world and the 6,336th biggest in the United States. Its market cap has decreased by 67.04% in one year.
Market Cap
2.34M
Enterprise Value
-8.40M
1-Year Change
-67.04%
Global Rank
Country Rank
#6,336 United States
Category
ChartMarket Cap Chart
Since November 17, 2020, Revelation Biosciences's market cap has decreased from $82.64M to $2.34M, a decrease of -97.16%. That is a compound annual growth rate of -44.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2026 | 2.34M | -50.55% |
| Dec 31, 2025 | 4.74M | 23.01% |
| Dec 31, 2024 | 3.85M | 22.31% |
| Dec 29, 2023 | 3.15M | -26.63% |
| Dec 30, 2022 | 4.29M | -92.55% |
| Dec 31, 2021 | 57.58M | -32.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Curis | 2.71M |
| NeuroSense Therapeutics | 2.64M |
| Clearmind Medicine | 2.58M |
| VivoSim Labs | 2.54M |
| Karyopharm Therapeutics | 2.54M |
| HCW Biologics | 2.50M |
| Calidi Biotherapeutics | 2.43M |
| Onconetix | 2.14M |